The AT2R agonist compound 21 prevented the development of lung fibrosis induced by BLM at day 0 or halted its progression at day 3 (39), suggesting that Ang II plays distinct roles depending on which receptor it binds to. The gene discussed is AGT; the disease is pulmonary fibrosis.